Sunday 14 June 2009

Low-Dose Naltrexone for Fibromyalgia & Chronic Fatigue Syndrome

"An exciting thing about LDN is that it's inexpensive and already on the market. Anecdotal evidence so far is very promising, as is the first clinical trial for FMS."


No comments:

Post a Comment